Fig. 5
From: Knockdown of DEPDC1B inhibits the development of glioblastoma
Knockdown of DEPDC1B inhibits tumor growth in mice xenograft models and intracranial xenograft models. a The volume of tumors in shCtrl group and shDEPDC1B-1 group was measured 18, 20, 22, 24, 26 days’ post-injection. b The average weight of tumors in shCtrl group and shDEPDC1B-1 group. c The tumors of mice in shCtrl group and shDEPDC1B-1 group. d The total bioluminescent intensity of tumors in shCtrl group and shDEPDC1B-1 group. e The bioluminescence imaging of tumors in shCtrl group and shDEPDC1B-1 group. f The Ki67 staining of tumor tissues in shCtrl group and shDEPDC1B-1 group (scale bar = 100 μm). g The bioluminescence imaging of intracranial tumors in shCtrl group and shDEPDC1B-1 group. h The intracranial tumors in shCtrl group and shDEPDC1B-1 group. i The Ki67 staining of intracranial tumor tissues in shCtrl group and shDEPDC1B-1 group (scale bar = 100 μm). The data were expressed as mean ± SD (n = 3), *P < 0.05, **P < 0.01, ***P < 0.001